109 related articles for article (PubMed ID: 33981800)
1. Broadening the Clinical Spectrum of Very Low Density Lipoprotein Receptor Associated Dysequilibrium Syndrome.
Wali GM; Wali G
Mov Disord Clin Pract; 2021 May; 8(4):619-623. PubMed ID: 33981800
[No Abstract] [Full Text] [Related]
2. A missense founder mutation in VLDLR is associated with Dysequilibrium Syndrome without quadrupedal locomotion.
Ali BR; Silhavy JL; Gleeson MJ; Gleeson JG; Al-Gazali L
BMC Med Genet; 2012 Sep; 13():80. PubMed ID: 22973972
[TBL] [Abstract][Full Text] [Related]
3. Very mild features of dysequilibrium syndrome associated with a novel VLDLR missense mutation.
Micalizzi A; Moroni I; Ginevrino M; Biagini T; Mazza T; Romani M; Valente EM
Neurogenetics; 2016 Jul; 17(3):191-5. PubMed ID: 27251579
[TBL] [Abstract][Full Text] [Related]
4. Impaired trafficking of the very low density lipoprotein receptor caused by missense mutations associated with dysequilibrium syndrome.
Kizhakkedath P; Loregger A; John A; Bleijlevens B; Al-Blooshi AS; Al-Hosani AH; Al-Nuaimi AM; Al-Gazali L; Zelcer N; Ali BR
Biochim Biophys Acta; 2014 Dec; 1843(12):2871-7. PubMed ID: 25173816
[TBL] [Abstract][Full Text] [Related]
5. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome.
Moheb LA; Tzschach A; Garshasbi M; Kahrizi K; Darvish H; Heshmati Y; Kordi A; Najmabadi H; Ropers HH; Kuss AW
Eur J Hum Genet; 2008 Feb; 16(2):270-3. PubMed ID: 18043714
[TBL] [Abstract][Full Text] [Related]
6. Degradation routes of trafficking-defective VLDLR mutants associated with Dysequilibrium syndrome.
Kizhakkedath P; John A; Al-Gazali L; Ali BR
Sci Rep; 2018 Jan; 8(1):1583. PubMed ID: 29371607
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene.
Türkmen S; Hoffmann K; Demirhan O; Aruoba D; Humphrey N; Mundlos S
Eur J Hum Genet; 2008 Sep; 16(9):1070-4. PubMed ID: 18364738
[TBL] [Abstract][Full Text] [Related]
8. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor.
Oka K; Ishimura-Oka K; Chu MJ; Sullivan M; Krushkal J; Li WH; Chan L
Eur J Biochem; 1994 Sep; 224(3):975-82. PubMed ID: 7925422
[TBL] [Abstract][Full Text] [Related]
9. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
10. The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII.
Ananyeva NM; Makogonenko YM; Kouiavskaia DV; Ruiz J; Limburg V; Meijer AB; Khrenov AV; Shima M; Strickland DK; Saenko EL
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):166-77. PubMed ID: 18277139
[TBL] [Abstract][Full Text] [Related]
11. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
[TBL] [Abstract][Full Text] [Related]
12. Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19.
Gåfvels ME; Paavola LG; Boyd CO; Nolan PM; Wittmaack F; Chawla A; Lazar MA; Bucan M; Angelin BO; Strauss JF
Endocrinology; 1994 Jul; 135(1):387-94. PubMed ID: 8013374
[TBL] [Abstract][Full Text] [Related]
13. Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport.
Wittmaack FM; Gåfvels ME; Bronner M; Matsuo H; McCrae KR; Tomaszewski JE; Robinson SL; Strickland DK; Strauss JF
Endocrinology; 1995 Jan; 136(1):340-8. PubMed ID: 7828550
[TBL] [Abstract][Full Text] [Related]
14. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
[TBL] [Abstract][Full Text] [Related]
15. Mutations in VLDLR as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome).
Boycott KM; Bonnemann C; Herz J; Neuert S; Beaulieu C; Scott JN; Venkatasubramanian A; Parboosingh JS
J Child Neurol; 2009 Oct; 24(10):1310-5. PubMed ID: 19332571
[TBL] [Abstract][Full Text] [Related]
16. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation.
Tiebel O; Oka K; Robinson K; Sullivan M; Martinez J; Nakamuta M; Ishimura-Oka K; Chan L
Atherosclerosis; 1999 Aug; 145(2):239-51. PubMed ID: 10488949
[TBL] [Abstract][Full Text] [Related]
17. Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization.
Oka K; Tzung KW; Sullivan M; Lindsay E; Baldini A; Chan L
Genomics; 1994 Mar; 20(2):298-300. PubMed ID: 8020981
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.
Tao H; Aakula S; Abumrad NN; Hajri T
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E68-79. PubMed ID: 19861583
[TBL] [Abstract][Full Text] [Related]
19. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
[TBL] [Abstract][Full Text] [Related]
20. Neuro-ophthalmologic findings in humans with quadrupedal locomotion.
Sarac O; Gulsuner S; Yildiz-Tasci Y; Ozcelik T; Kansu T
Ophthalmic Genet; 2012 Dec; 33(4):249-52. PubMed ID: 22686558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
